Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Firearms | 25 | 2024 | 632 | 5.600 |
Why?
|
Wounds, Gunshot | 20 | 2024 | 588 | 4.630 |
Why?
|
Spinal Injuries | 4 | 2023 | 300 | 1.710 |
Why?
|
Licensure | 4 | 2017 | 127 | 1.170 |
Why?
|
Wounds and Injuries | 6 | 2024 | 2514 | 1.140 |
Why?
|
Off-Road Motor Vehicles | 2 | 2017 | 17 | 0.950 |
Why?
|
Occult Blood | 2 | 2016 | 199 | 0.940 |
Why?
|
Automobile Driving | 4 | 2017 | 442 | 0.860 |
Why?
|
Wounds, Nonpenetrating | 4 | 2023 | 809 | 0.840 |
Why?
|
Violence | 7 | 2023 | 938 | 0.840 |
Why?
|
Anal Canal | 2 | 2016 | 376 | 0.830 |
Why?
|
Accidents, Traffic | 4 | 2017 | 819 | 0.820 |
Why?
|
Opiate Alkaloids | 1 | 2021 | 27 | 0.740 |
Why?
|
Neck Injuries | 1 | 2022 | 162 | 0.710 |
Why?
|
Funnel Chest | 1 | 2021 | 75 | 0.700 |
Why?
|
Moral Obligations | 1 | 2020 | 91 | 0.660 |
Why?
|
Physical Examination | 2 | 2016 | 1262 | 0.660 |
Why?
|
Tourniquets | 1 | 2020 | 111 | 0.630 |
Why?
|
Cervical Vertebrae | 5 | 2023 | 982 | 0.630 |
Why?
|
Decanoates | 5 | 2012 | 55 | 0.620 |
Why?
|
Mass Casualty Incidents | 3 | 2018 | 180 | 0.610 |
Why?
|
Abdominal Wound Closure Techniques | 2 | 2018 | 34 | 0.580 |
Why?
|
Glycerol | 5 | 2012 | 274 | 0.570 |
Why?
|
Hirschsprung Disease | 1 | 2019 | 163 | 0.570 |
Why?
|
Ectodermal Dysplasia | 1 | 2018 | 107 | 0.570 |
Why?
|
Public Policy | 2 | 2020 | 551 | 0.540 |
Why?
|
Hemostatic Techniques | 1 | 2017 | 116 | 0.510 |
Why?
|
Radiography, Abdominal | 1 | 2019 | 541 | 0.510 |
Why?
|
Automobile Driver Examination | 1 | 2015 | 25 | 0.490 |
Why?
|
Pediatrics | 4 | 2024 | 3624 | 0.490 |
Why?
|
Tympanic Membrane Perforation | 2 | 2012 | 45 | 0.490 |
Why?
|
Organizational Culture | 1 | 2018 | 512 | 0.480 |
Why?
|
Appendicitis | 2 | 2018 | 689 | 0.470 |
Why?
|
Appendectomy | 1 | 2018 | 443 | 0.470 |
Why?
|
Hernia, Inguinal | 1 | 2017 | 225 | 0.470 |
Why?
|
Extremities | 1 | 2020 | 870 | 0.460 |
Why?
|
Tissue Adhesives | 2 | 2013 | 179 | 0.450 |
Why?
|
Pain, Postoperative | 3 | 2021 | 1765 | 0.440 |
Why?
|
Cyanoacrylates | 1 | 2013 | 47 | 0.440 |
Why?
|
Colon | 2 | 2019 | 1805 | 0.430 |
Why?
|
Extracorporeal Membrane Oxygenation | 5 | 2022 | 1482 | 0.410 |
Why?
|
Solitary Fibrous Tumors | 1 | 2012 | 70 | 0.390 |
Why?
|
Biocompatible Materials | 4 | 2013 | 1704 | 0.390 |
Why?
|
Emergency Service, Hospital | 7 | 2021 | 7955 | 0.370 |
Why?
|
Polymers | 5 | 2012 | 1630 | 0.370 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2016 | 2442 | 0.360 |
Why?
|
Hemorrhage | 2 | 2020 | 3461 | 0.350 |
Why?
|
Neoplasms, Vascular Tissue | 1 | 2010 | 25 | 0.350 |
Why?
|
Child | 29 | 2024 | 80891 | 0.350 |
Why?
|
Humans | 95 | 2024 | 768393 | 0.350 |
Why?
|
Axilla | 1 | 2012 | 628 | 0.340 |
Why?
|
Splenic Neoplasms | 1 | 2010 | 97 | 0.340 |
Why?
|
Massachusetts | 7 | 2024 | 8902 | 0.330 |
Why?
|
Materials Testing | 2 | 2012 | 872 | 0.330 |
Why?
|
Testicular Hormones | 5 | 2006 | 188 | 0.320 |
Why?
|
Public Health | 2 | 2022 | 2682 | 0.320 |
Why?
|
Abdominal Pain | 2 | 2018 | 1070 | 0.320 |
Why?
|
Axillary Artery | 1 | 2009 | 48 | 0.320 |
Why?
|
Urachus | 1 | 2008 | 18 | 0.310 |
Why?
|
Adolescent | 28 | 2024 | 89184 | 0.310 |
Why?
|
Wounds, Stab | 1 | 2009 | 72 | 0.310 |
Why?
|
Analgesics, Opioid | 3 | 2024 | 3836 | 0.310 |
Why?
|
United States | 22 | 2024 | 73150 | 0.310 |
Why?
|
Trauma Centers | 3 | 2023 | 947 | 0.310 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 3922 | 0.300 |
Why?
|
Diatrizoate Meglumine | 1 | 2007 | 79 | 0.290 |
Why?
|
Substance-Related Disorders | 2 | 2021 | 4429 | 0.290 |
Why?
|
Anus Diseases | 1 | 2007 | 54 | 0.280 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2008 | 99 | 0.280 |
Why?
|
Child Advocacy | 2 | 2024 | 48 | 0.280 |
Why?
|
Physicians | 3 | 2022 | 4614 | 0.280 |
Why?
|
Rectal Fistula | 1 | 2007 | 76 | 0.280 |
Why?
|
Enema | 1 | 2007 | 141 | 0.270 |
Why?
|
Infant | 17 | 2024 | 36510 | 0.270 |
Why?
|
Physician-Patient Relations | 2 | 2020 | 3267 | 0.260 |
Why?
|
Intussusception | 1 | 2007 | 117 | 0.260 |
Why?
|
Guideline Adherence | 1 | 2016 | 2240 | 0.260 |
Why?
|
Athletic Injuries | 1 | 2016 | 1245 | 0.260 |
Why?
|
Pyloric Stenosis, Hypertrophic | 2 | 2016 | 11 | 0.260 |
Why?
|
Retrospective Studies | 26 | 2024 | 81801 | 0.260 |
Why?
|
Pylorus | 2 | 2017 | 86 | 0.250 |
Why?
|
Safety | 4 | 2024 | 1159 | 0.250 |
Why?
|
Self Report | 1 | 2017 | 3766 | 0.250 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2004 | 736 | 0.250 |
Why?
|
Prostheses and Implants | 1 | 2012 | 1279 | 0.250 |
Why?
|
Communication | 2 | 2020 | 3912 | 0.250 |
Why?
|
Growth Inhibitors | 4 | 2001 | 375 | 0.240 |
Why?
|
Emergency Medical Services | 1 | 2017 | 1946 | 0.240 |
Why?
|
Brain Concussion | 1 | 2016 | 1433 | 0.240 |
Why?
|
Patient Advocacy | 2 | 2024 | 362 | 0.240 |
Why?
|
Cities | 2 | 2024 | 543 | 0.230 |
Why?
|
Physician's Role | 2 | 2023 | 926 | 0.230 |
Why?
|
Counseling | 2 | 2024 | 1553 | 0.230 |
Why?
|
Health Policy | 1 | 2016 | 2698 | 0.220 |
Why?
|
Calcinosis | 1 | 2012 | 1481 | 0.220 |
Why?
|
Abscess | 1 | 2007 | 606 | 0.220 |
Why?
|
Societies, Medical | 4 | 2024 | 3960 | 0.220 |
Why?
|
Glycoproteins | 5 | 2006 | 2204 | 0.210 |
Why?
|
Male | 53 | 2024 | 364902 | 0.210 |
Why?
|
Adrenal Gland Diseases | 1 | 2004 | 141 | 0.210 |
Why?
|
Guidelines as Topic | 3 | 2019 | 1397 | 0.210 |
Why?
|
Contusions | 1 | 2003 | 78 | 0.210 |
Why?
|
Child, Preschool | 17 | 2024 | 42650 | 0.200 |
Why?
|
Gastric Outlet Obstruction | 2 | 2017 | 55 | 0.200 |
Why?
|
Intestinal Obstruction | 2 | 2024 | 435 | 0.200 |
Why?
|
Wound Healing | 2 | 2012 | 2813 | 0.190 |
Why?
|
Adult | 26 | 2024 | 223640 | 0.190 |
Why?
|
Isoantibodies | 3 | 2016 | 682 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4047 | 0.190 |
Why?
|
HLA Antigens | 3 | 2016 | 1337 | 0.190 |
Why?
|
Infant, Newborn | 12 | 2022 | 26411 | 0.190 |
Why?
|
Heart Injuries | 1 | 2003 | 207 | 0.190 |
Why?
|
Receptors, Peptide | 2 | 1999 | 280 | 0.190 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 7463 | 0.180 |
Why?
|
Female | 47 | 2024 | 397089 | 0.180 |
Why?
|
New York | 2 | 2021 | 884 | 0.180 |
Why?
|
Laparoscopy | 3 | 2009 | 2056 | 0.180 |
Why?
|
Health Care Costs | 1 | 2014 | 3267 | 0.180 |
Why?
|
Duodenum | 2 | 2019 | 495 | 0.180 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 4076 | 0.180 |
Why?
|
Multiple Trauma | 1 | 2003 | 369 | 0.170 |
Why?
|
Cystadenocarcinoma | 1 | 1999 | 54 | 0.170 |
Why?
|
Hospitals, General | 1 | 2024 | 807 | 0.170 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2019 | 50 | 0.170 |
Why?
|
Homicide | 2 | 2021 | 294 | 0.170 |
Why?
|
Kidney Transplantation | 4 | 2016 | 4300 | 0.170 |
Why?
|
Recurrence | 3 | 2024 | 8506 | 0.170 |
Why?
|
Mortality | 1 | 2011 | 2917 | 0.160 |
Why?
|
Ganglia, Autonomic | 1 | 2019 | 43 | 0.160 |
Why?
|
Isochromosomes | 1 | 2018 | 16 | 0.160 |
Why?
|
Specialties, Surgical | 1 | 2023 | 393 | 0.160 |
Why?
|
Financial Management | 1 | 2020 | 161 | 0.160 |
Why?
|
Ileostomy | 1 | 2019 | 122 | 0.150 |
Why?
|
Intestine, Small | 1 | 2024 | 1218 | 0.150 |
Why?
|
Lung Injury | 1 | 2003 | 433 | 0.150 |
Why?
|
Epidermolysis Bullosa, Junctional | 1 | 2017 | 12 | 0.150 |
Why?
|
Child Mortality | 1 | 2020 | 204 | 0.150 |
Why?
|
Integrin beta4 | 1 | 2017 | 29 | 0.150 |
Why?
|
Length of Stay | 3 | 2024 | 6519 | 0.150 |
Why?
|
Benzodiazepines | 1 | 2024 | 1139 | 0.150 |
Why?
|
Cystic Fibrosis | 1 | 2007 | 1285 | 0.150 |
Why?
|
Paraneoplastic Endocrine Syndromes | 1 | 1997 | 29 | 0.150 |
Why?
|
Virilism | 1 | 1997 | 28 | 0.150 |
Why?
|
Androgen-Insensitivity Syndrome | 1 | 1997 | 33 | 0.150 |
Why?
|
Acute Disease | 4 | 2018 | 7242 | 0.140 |
Why?
|
Tissue Donors | 3 | 2016 | 2389 | 0.140 |
Why?
|
Genital Neoplasms, Male | 1 | 1997 | 68 | 0.140 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2018 | 431 | 0.140 |
Why?
|
Circumcision, Male | 1 | 2018 | 148 | 0.140 |
Why?
|
Young Adult | 12 | 2023 | 60049 | 0.140 |
Why?
|
Facial Injuries | 1 | 2018 | 191 | 0.140 |
Why?
|
Inappropriate Prescribing | 1 | 2019 | 213 | 0.140 |
Why?
|
Stents | 1 | 2009 | 3201 | 0.140 |
Why?
|
Canada | 1 | 2022 | 2139 | 0.140 |
Why?
|
Ovarian Neoplasms | 5 | 2018 | 4907 | 0.140 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2020 | 794 | 0.130 |
Why?
|
Bites and Stings | 1 | 2017 | 94 | 0.130 |
Why?
|
Radiography | 3 | 2022 | 6993 | 0.130 |
Why?
|
Tissue Adhesions | 2 | 2024 | 223 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 7 | 2023 | 20765 | 0.130 |
Why?
|
Complement C1q | 1 | 2016 | 93 | 0.130 |
Why?
|
Introns | 1 | 2018 | 968 | 0.120 |
Why?
|
Teratoma | 1 | 2018 | 405 | 0.120 |
Why?
|
Ethanol | 1 | 2021 | 1332 | 0.120 |
Why?
|
Chinchilla | 2 | 2012 | 77 | 0.120 |
Why?
|
Music | 1 | 2018 | 247 | 0.120 |
Why?
|
Unnecessary Procedures | 1 | 2018 | 419 | 0.120 |
Why?
|
Scalp | 1 | 2017 | 391 | 0.120 |
Why?
|
Internship and Residency | 3 | 2024 | 5949 | 0.120 |
Why?
|
Mutation | 2 | 2018 | 30228 | 0.120 |
Why?
|
Genetic Counseling | 1 | 2018 | 634 | 0.110 |
Why?
|
History, 21st Century | 1 | 2020 | 1575 | 0.110 |
Why?
|
Contrast Media | 1 | 2007 | 5336 | 0.110 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 937 | 0.110 |
Why?
|
Inflammation | 1 | 2013 | 10863 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2024 | 5313 | 0.110 |
Why?
|
Research Support as Topic | 1 | 2017 | 696 | 0.110 |
Why?
|
Hospital Charges | 1 | 2015 | 351 | 0.110 |
Why?
|
Gonadal Steroid Hormones | 1 | 1997 | 708 | 0.110 |
Why?
|
Suicide, Attempted | 2 | 2021 | 1409 | 0.110 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 494 | 0.110 |
Why?
|
Hypocalcemia | 1 | 2014 | 203 | 0.110 |
Why?
|
Registries | 3 | 2020 | 8379 | 0.100 |
Why?
|
HLA-DP Antigens | 1 | 2012 | 25 | 0.100 |
Why?
|
Surface Properties | 2 | 2013 | 1167 | 0.100 |
Why?
|
Pancreas | 1 | 2019 | 1702 | 0.100 |
Why?
|
Elastomers | 1 | 2012 | 69 | 0.100 |
Why?
|
Platelet Count | 1 | 2015 | 784 | 0.100 |
Why?
|
Health Surveys | 1 | 2022 | 4056 | 0.100 |
Why?
|
Dogs | 1 | 2017 | 3846 | 0.100 |
Why?
|
Pancreatic Neoplasms | 3 | 2018 | 5443 | 0.100 |
Why?
|
Suicidal Ideation | 2 | 2021 | 1462 | 0.100 |
Why?
|
History, 20th Century | 1 | 2020 | 2771 | 0.100 |
Why?
|
Testicular Neoplasms | 1 | 2018 | 805 | 0.100 |
Why?
|
Postoperative Complications | 5 | 2018 | 15881 | 0.100 |
Why?
|
HLA-C Antigens | 1 | 2012 | 146 | 0.100 |
Why?
|
Genital Neoplasms, Female | 1 | 1997 | 539 | 0.100 |
Why?
|
Mitochondrial ADP, ATP Translocases | 1 | 1991 | 11 | 0.100 |
Why?
|
Syndrome | 1 | 2018 | 3275 | 0.100 |
Why?
|
Spleen | 1 | 2017 | 2296 | 0.090 |
Why?
|
Thyroid Diseases | 1 | 2014 | 387 | 0.090 |
Why?
|
Curriculum | 1 | 2024 | 3776 | 0.090 |
Why?
|
Cohort Studies | 6 | 2023 | 41795 | 0.090 |
Why?
|
Lobbying | 1 | 2011 | 32 | 0.090 |
Why?
|
Myringoplasty | 1 | 2010 | 12 | 0.090 |
Why?
|
Mitochondria, Liver | 1 | 1991 | 190 | 0.090 |
Why?
|
Stomach | 2 | 2013 | 703 | 0.090 |
Why?
|
Neuroendocrine Tumors | 1 | 2017 | 658 | 0.090 |
Why?
|
Tympanic Membrane | 1 | 2012 | 232 | 0.090 |
Why?
|
Pain Measurement | 2 | 2019 | 3581 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1959 | 0.090 |
Why?
|
Respiratory Insufficiency | 1 | 1999 | 1241 | 0.090 |
Why?
|
Hospital Mortality | 1 | 2024 | 5367 | 0.090 |
Why?
|
Guided Tissue Regeneration | 1 | 2010 | 88 | 0.080 |
Why?
|
Physicians, Primary Care | 1 | 2016 | 623 | 0.080 |
Why?
|
Statistics, Nonparametric | 2 | 2019 | 2862 | 0.080 |
Why?
|
Drainage | 2 | 2022 | 1184 | 0.080 |
Why?
|
Follow-Up Studies | 8 | 2018 | 39407 | 0.080 |
Why?
|
Necrosis | 1 | 2013 | 1621 | 0.080 |
Why?
|
Autistic Disorder | 1 | 2018 | 1240 | 0.080 |
Why?
|
Age Factors | 4 | 2019 | 18471 | 0.080 |
Why?
|
Venous Thrombosis | 1 | 2018 | 1317 | 0.080 |
Why?
|
Thyroidectomy | 1 | 2014 | 914 | 0.080 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2015 | 887 | 0.080 |
Why?
|
Splenectomy | 1 | 2010 | 392 | 0.080 |
Why?
|
Chronic Disease | 3 | 2016 | 9379 | 0.080 |
Why?
|
Pulmonary Blastoma | 1 | 2008 | 43 | 0.080 |
Why?
|
Anti-Mullerian Hormone | 5 | 2006 | 415 | 0.080 |
Why?
|
Tissue and Organ Procurement | 1 | 2016 | 986 | 0.080 |
Why?
|
Lizards | 1 | 2008 | 50 | 0.070 |
Why?
|
Regression Analysis | 1 | 2017 | 6350 | 0.070 |
Why?
|
Reoperation | 1 | 2018 | 4341 | 0.070 |
Why?
|
State Government | 1 | 2011 | 389 | 0.070 |
Why?
|
Logistic Models | 2 | 2015 | 13323 | 0.070 |
Why?
|
Trauma Severity Indices | 1 | 2009 | 479 | 0.070 |
Why?
|
Antibodies | 1 | 2016 | 2425 | 0.070 |
Why?
|
Middle Aged | 11 | 2021 | 223491 | 0.070 |
Why?
|
Biopsy, Needle | 1 | 2012 | 1627 | 0.070 |
Why?
|
Treatment Outcome | 10 | 2024 | 65379 | 0.070 |
Why?
|
Risk Factors | 9 | 2020 | 74962 | 0.070 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11120 | 0.070 |
Why?
|
Air | 1 | 2007 | 187 | 0.070 |
Why?
|
Rats | 6 | 2013 | 23835 | 0.070 |
Why?
|
Catheters, Indwelling | 1 | 2009 | 436 | 0.070 |
Why?
|
Glasgow Coma Scale | 2 | 2019 | 580 | 0.070 |
Why?
|
Incidence | 5 | 2021 | 21544 | 0.070 |
Why?
|
Survival Rate | 3 | 2009 | 12870 | 0.070 |
Why?
|
Needles | 1 | 2009 | 461 | 0.060 |
Why?
|
Seizures | 1 | 2018 | 3000 | 0.060 |
Why?
|
Propensity Score | 2 | 2024 | 1962 | 0.060 |
Why?
|
Graft Rejection | 2 | 2016 | 4505 | 0.060 |
Why?
|
Abdominal Injuries | 2 | 2019 | 364 | 0.060 |
Why?
|
Testis | 2 | 1999 | 783 | 0.060 |
Why?
|
Pulmonary Embolism | 1 | 2018 | 2587 | 0.060 |
Why?
|
Ovary | 2 | 2000 | 960 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2188 | 0.060 |
Why?
|
Thoracic Surgical Procedures | 1 | 2008 | 350 | 0.060 |
Why?
|
Cholangiography | 1 | 2004 | 182 | 0.060 |
Why?
|
Gastrinoma | 1 | 2003 | 21 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7861 | 0.060 |
Why?
|
Holidays | 1 | 2023 | 41 | 0.060 |
Why?
|
Choledocholithiasis | 1 | 2004 | 50 | 0.060 |
Why?
|
Time Factors | 5 | 2021 | 40272 | 0.060 |
Why?
|
Lung Neoplasms | 1 | 2008 | 13576 | 0.050 |
Why?
|
Tissue Scaffolds | 1 | 2010 | 950 | 0.050 |
Why?
|
Smoking | 1 | 2020 | 9111 | 0.050 |
Why?
|
Angiography | 1 | 2009 | 1598 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2015 | 3857 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3438 | 0.050 |
Why?
|
Animals | 15 | 2017 | 169337 | 0.050 |
Why?
|
Case Management | 1 | 2004 | 276 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7453 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 1991 | 3781 | 0.050 |
Why?
|
Catheterization | 2 | 2022 | 1431 | 0.050 |
Why?
|
Ultrasonography | 3 | 2019 | 6001 | 0.050 |
Why?
|
Receptors, Transforming Growth Factor beta | 2 | 1999 | 306 | 0.050 |
Why?
|
Radiotherapy | 1 | 2008 | 1509 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10844 | 0.050 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2004 | 520 | 0.050 |
Why?
|
Rubidium | 1 | 2000 | 121 | 0.050 |
Why?
|
Graft Survival | 3 | 2016 | 3900 | 0.040 |
Why?
|
Spinal Cord Injuries | 1 | 2008 | 929 | 0.040 |
Why?
|
Thoracic Injuries | 1 | 2003 | 288 | 0.040 |
Why?
|
Prognosis | 2 | 2018 | 30022 | 0.040 |
Why?
|
Phenotype | 1 | 2018 | 16721 | 0.040 |
Why?
|
Pulmonary Artery | 2 | 2018 | 1945 | 0.040 |
Why?
|
Leydig Cells | 1 | 1999 | 55 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26375 | 0.040 |
Why?
|
Tracheal Stenosis | 1 | 2001 | 228 | 0.040 |
Why?
|
Cell Transplantation | 1 | 2001 | 475 | 0.040 |
Why?
|
Diltiazem | 1 | 1999 | 132 | 0.040 |
Why?
|
Mullerian Ducts | 1 | 1999 | 203 | 0.040 |
Why?
|
Esophageal Atresia | 1 | 2001 | 225 | 0.040 |
Why?
|
Risk Assessment | 3 | 2018 | 24318 | 0.040 |
Why?
|
Drug Utilization Review | 1 | 2019 | 248 | 0.040 |
Why?
|
Tumor Cells, Cultured | 3 | 2001 | 6132 | 0.040 |
Why?
|
Advanced Cardiac Life Support | 1 | 2018 | 79 | 0.040 |
Why?
|
Femoral Vein | 1 | 2018 | 154 | 0.040 |
Why?
|
Abdominal Cavity | 1 | 2018 | 34 | 0.040 |
Why?
|
Ascites | 1 | 1999 | 338 | 0.040 |
Why?
|
COS Cells | 1 | 1999 | 1135 | 0.040 |
Why?
|
Esophagectomy | 1 | 2001 | 482 | 0.040 |
Why?
|
Gastroenteritis | 1 | 2018 | 236 | 0.030 |
Why?
|
Alcoholic Intoxication | 1 | 2018 | 171 | 0.030 |
Why?
|
Radiography, Interventional | 1 | 2004 | 1131 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6541 | 0.030 |
Why?
|
Pneumonia | 1 | 2008 | 2163 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 2001 | 708 | 0.030 |
Why?
|
Traumatology | 1 | 2017 | 101 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8562 | 0.030 |
Why?
|
Tissue Expansion | 1 | 2017 | 163 | 0.030 |
Why?
|
Puberty, Precocious | 1 | 1997 | 166 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 1997 | 9198 | 0.030 |
Why?
|
Calcium Channel Blockers | 1 | 1999 | 692 | 0.030 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2018 | 156 | 0.030 |
Why?
|
Prospective Studies | 2 | 2017 | 54920 | 0.030 |
Why?
|
Laparotomy | 1 | 2017 | 459 | 0.030 |
Why?
|
Risk | 1 | 2007 | 9636 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2008 | 13020 | 0.030 |
Why?
|
Histocompatibility Testing | 1 | 2016 | 716 | 0.030 |
Why?
|
Adenosine Triphosphate | 2 | 1991 | 2002 | 0.030 |
Why?
|
Autopsy | 1 | 2018 | 1013 | 0.030 |
Why?
|
Adrenal Glands | 1 | 1997 | 557 | 0.030 |
Why?
|
Surgicenters | 1 | 2014 | 50 | 0.030 |
Why?
|
Ownership | 1 | 2017 | 344 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2024 | 2122 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12092 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2018 | 1837 | 0.030 |
Why?
|
Needs Assessment | 1 | 2019 | 1142 | 0.030 |
Why?
|
Stem Cells | 1 | 2006 | 3539 | 0.030 |
Why?
|
Resuscitation | 1 | 2018 | 679 | 0.030 |
Why?
|
Survival Analysis | 2 | 2017 | 10117 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2019 | 997 | 0.030 |
Why?
|
Hypoparathyroidism | 1 | 2014 | 136 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15455 | 0.030 |
Why?
|
Research | 1 | 2021 | 1981 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2024 | 2721 | 0.030 |
Why?
|
Triage | 1 | 2019 | 994 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2014 | 1065 | 0.030 |
Why?
|
California | 1 | 2016 | 1443 | 0.030 |
Why?
|
Face | 1 | 2018 | 1031 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2024 | 2412 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2018 | 2524 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2010 | 36849 | 0.020 |
Why?
|
Cell Division | 1 | 1999 | 4479 | 0.020 |
Why?
|
Fetus | 1 | 1999 | 1883 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2023 | 2588 | 0.020 |
Why?
|
SEER Program | 1 | 2017 | 1474 | 0.020 |
Why?
|
Disaster Planning | 1 | 2018 | 560 | 0.020 |
Why?
|
Abdomen | 1 | 2018 | 1136 | 0.020 |
Why?
|
Transfection | 1 | 1999 | 5764 | 0.020 |
Why?
|
Reimbursement, Incentive | 1 | 2016 | 548 | 0.020 |
Why?
|
Polyglycolic Acid | 1 | 2012 | 408 | 0.020 |
Why?
|
CHO Cells | 2 | 2006 | 1380 | 0.020 |
Why?
|
Politics | 1 | 2018 | 821 | 0.020 |
Why?
|
Heterozygote | 1 | 2017 | 2791 | 0.020 |
Why?
|
Aged | 6 | 2024 | 171562 | 0.020 |
Why?
|
Proton-Translocating ATPases | 1 | 1991 | 113 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 655 | 0.020 |
Why?
|
Phosphorus | 1 | 1991 | 336 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1991 | 2087 | 0.020 |
Why?
|
Cricetinae | 2 | 2006 | 2423 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2006 | 8634 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2019 | 1673 | 0.020 |
Why?
|
Algorithms | 3 | 2019 | 14154 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1999 | 6510 | 0.020 |
Why?
|
Waiting Lists | 1 | 2014 | 780 | 0.020 |
Why?
|
Catalysis | 1 | 1991 | 768 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2008 | 9433 | 0.020 |
Why?
|
Mitochondria, Heart | 1 | 1991 | 236 | 0.020 |
Why?
|
Patient Compliance | 1 | 2019 | 2693 | 0.020 |
Why?
|
Peritoneal Diseases | 1 | 2009 | 76 | 0.020 |
Why?
|
Clinical Competence | 1 | 2024 | 4848 | 0.020 |
Why?
|
Suicide | 1 | 2020 | 1607 | 0.020 |
Why?
|
Surgical Flaps | 1 | 2017 | 1682 | 0.020 |
Why?
|
Heart Arrest | 1 | 2018 | 1516 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2783 | 0.020 |
Why?
|
General Surgery | 1 | 2019 | 1713 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2337 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 1999 | 1597 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 1999 | 13423 | 0.020 |
Why?
|
Sus scrofa | 1 | 2009 | 430 | 0.020 |
Why?
|
Lactic Acid | 1 | 2012 | 1140 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 11854 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 3212 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2014 | 1176 | 0.020 |
Why?
|
Peptide Fragments | 1 | 1999 | 5151 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 1999 | 17626 | 0.020 |
Why?
|
Hemodynamics | 1 | 2017 | 4199 | 0.020 |
Why?
|
Kinetics | 2 | 1991 | 6333 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59686 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2008 | 946 | 0.020 |
Why?
|
Verapamil | 1 | 2006 | 242 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3627 | 0.020 |
Why?
|
Elasticity | 1 | 2008 | 657 | 0.020 |
Why?
|
Proteins | 1 | 2000 | 6006 | 0.020 |
Why?
|
Absorbable Implants | 1 | 2008 | 339 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5451 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2009 | 1890 | 0.020 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2004 | 44 | 0.010 |
Why?
|
Parents | 1 | 2018 | 3596 | 0.010 |
Why?
|
Muscles | 1 | 2009 | 1582 | 0.010 |
Why?
|
Gastric Acidity Determination | 1 | 2003 | 56 | 0.010 |
Why?
|
Gastrins | 1 | 2003 | 75 | 0.010 |
Why?
|
Skin | 1 | 2017 | 4499 | 0.010 |
Why?
|
Biopsy, Fine-Needle | 1 | 2009 | 1132 | 0.010 |
Why?
|
Sex Factors | 1 | 2018 | 10654 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14737 | 0.010 |
Why?
|
Molecular Structure | 1 | 2008 | 1884 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2010 | 1371 | 0.010 |
Why?
|
Nanostructures | 1 | 2008 | 553 | 0.010 |
Why?
|
Models, Animal | 1 | 2009 | 2124 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2012 | 1891 | 0.010 |
Why?
|
Patient Readmission | 1 | 2016 | 3312 | 0.010 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2004 | 236 | 0.010 |
Why?
|
Peptic Ulcer | 1 | 2003 | 222 | 0.010 |
Why?
|
Mesenchymal Stem Cells | 1 | 2012 | 1671 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14784 | 0.010 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2000 | 73 | 0.010 |
Why?
|
Benzimidazoles | 1 | 2006 | 864 | 0.010 |
Why?
|
Equipment Design | 1 | 2009 | 3529 | 0.010 |
Why?
|
Lung | 1 | 1999 | 10089 | 0.010 |
Why?
|
Hyperplasia | 1 | 2003 | 1153 | 0.010 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2000 | 239 | 0.010 |
Why?
|
Swine | 1 | 2009 | 5994 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2006 | 1926 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 2001 | 993 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2000 | 710 | 0.010 |
Why?
|
Mice, SCID | 1 | 2001 | 2632 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 2001 | 1232 | 0.010 |
Why?
|
Blood Proteins | 1 | 2000 | 1186 | 0.010 |
Why?
|
Ligands | 1 | 2000 | 3283 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 3731 | 0.010 |
Why?
|
Mice | 3 | 2006 | 82017 | 0.010 |
Why?
|
Phosphorus Radioisotopes | 1 | 1991 | 100 | 0.010 |
Why?
|
Oxygen Isotopes | 1 | 1991 | 43 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18362 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 17135 | 0.010 |
Why?
|
Oxidative Phosphorylation | 1 | 1991 | 501 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1999 | 8199 | 0.000 |
Why?
|
Phosphates | 1 | 1991 | 765 | 0.000 |
Why?
|
DNA | 1 | 1999 | 7211 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1999 | 12805 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1999 | 19022 | 0.000 |
Why?
|
Blood Pressure | 1 | 1999 | 8541 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 13697 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2001 | 15939 | 0.000 |
Why?
|
Signal Transduction | 1 | 2006 | 23631 | 0.000 |
Why?
|
Cell Differentiation | 1 | 2000 | 11668 | 0.000 |
Why?
|
Models, Biological | 1 | 1991 | 9493 | 0.000 |
Why?
|